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Metal based biologically active compounds have been synthesized by microwave assisted template condensation method 
and characterized by spectro-analytical techniques like molar conductance, UV-visible, infrared and mass spectroscopy and 
thermogravimetric analysis. The metal is arranged in octahedral geometry surrounded by tetradentate ligand framework. The 
binding affinity of all the metal complexes has been evaluated theoretically by molecular docking studies against epidermal 
growth factor receptor (EGFR) and tyrosine kinase (TRK) receptor molecules which are further verified by in vitro 
anticancer activity. Complex [Cr(C16H11N4O2)(NO3)2]NO3 have showed potent in vitro cytotoxicity (IC50 value 39.5μM) 
against SCC4 cancer cell line. Antioxidant study has also performed by DPPH assay and significant results are found. 
[Fe(C16H11N4O2)(OAc)2]OAc and [Cr(C16H11N4O2) (OAc)2]OAc are most effective antioxidants with 78.7% and 76.8% free 
radical scavenging activity, respectively. 
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Nitrogen and oxygen containing ligand moiety has a 
strong affinity to form stable transition metals 
complexes and received a huge attention because of 
their considerable biological activities
1-4
. This kind of 
molecules has shown diverse applications such as 
catalysis, enzyme mimetic activity, chemical sensors, 
selective metal ion recovery, and pharmacology
5
. 
Isatin is one of such kind of ligand systems which has 
a wide variety of pharmacological applications 
including anticancer activity
6-7
. Isatin is a versatile 
ligand with one nitrogen and two oxygen donor atoms 
and it is a core constituent of many alkaloids, drugs, 
dyes, pesticides and analytical reagents. A large 
number of structurally diverse derivatives of isatin 
have been developed due to its synthetic versatility 
which includes, analogues derived from aryl ring 
modification or by substituting/modifying the 
nitrogen/carbonyl groups of indole ring
8
. It has been 
proven by research that biological activity of such 
type of molecules generally increases on their 
complexation with transition metal ions
9
. These 
compounds generally inhibit the cancerous tumor 
growth by interacting with a number of intracellular 




The coordination potential of these ligand 
frameworks and their diverse applications motivated 
us to explore new coordination compounds derived 
from isatin, evaluating their antioxidant potential and 
anticancer activity against human cancer cell line. 
This article deals with microwave assisted template 
synthesis of macrocyclic metal complexes derived 
from benzene-1,4-dicarbohydrazide and 1H-indole-2, 
3-dione (isatin) with trivalent transition metal Cr(III) 
and Fe(III) salts. The metal complexes were assessed 
for their antioxidant activity and cytotoxicity against 
head and neck cancer cell line Squamous cell 
carcinoma (SCC4). Moreover, molecular docking 
studies were performed to predict the binding energy 
of synthesized compounds to the molecular target 
Epidermal Growth Factor Receptor (EGFR) Kinase 
and tyrosine kinase (TRK). EGFR and TRK are 
important molecular targets for the development of 
novel anticancer drugs. In many solid tumors like 
head and neck, ovarian and colon tumors cell lines an 
over expression of EGFR has been detected
11
 which 
signals through tyrosine kinase. Both of these have 
been proven as attractive oncology targets for 
therapeutic intrusions due to their significant roles of 
abnormal signaling in cancer cells. 




Materials and Methods 
The chemicals used in study including isatin, 
dimethyl-phenyl-isophthalate, hydrazine hydrate, 
metal salts were purchased from Sigma Aldrich. 
Solvents used in the study were purchased from 
Merck India. The CHN analysis was recorded using a 
Perkin Elmer 2400 elemental analyzer. The FTIR 
spectra were recorded in the range 4000–400 cm
-1
 on 
Thermo Scientific Nicolet S 50 FTIR spectro-
photometer using KBr pallets. Ultraviolet–visible 
spectra were recorded in DMSO on Perkin Elmer 
Lambda 25 spectrophotometer at room temperature. 
The thermogravimetric analysis (TGA) was 
performed on Perkin Elmer thermoanalyzer between 
temperatures 0-1000
 




Synthesis of benzene-1,4-dicarbohydrazide 
A mixture of dimethyl-phenyl-isophthalate  
(10 mmol) and 2 mL hydrazine hydrate (98%) in  
4-5mL ethanol was irradiated at 300 W for 4-5 min.  
The resulting mixture was kept to get the room 
temperature and then the reaction mixture was  
poured onto ice cold water. The precipitate thus 
obtained was filtered and recrystallized by using 
ethanol. Yield ~85% (Scheme 1). 
 
Template synthesis of Cr(III) and Fe(III) complexes of 
benzene-1, 4-dicarbohydrazide and 1H-indole-2, 3-dione  
Benzene-1, 4-dicarbohydrazide and respective 
metal salt were mixed in 1:1 molar ratio in a grinder. 
After that the mixture was irradiated at 300 W. in 
UWave-1000, microwave synthesizer by taking  
8-10 ml of methanol and 4-5 drops of dil. HCl. After 
3-4 min, an equimolar amount of 1H-indole-2,  
3-dione (isatin) was added to the reaction mixture and 
it was further irradiated for 8-10 min. Colored 
precipitates were produced (~75-82%) which were 
washed with methanol, diethyl ether and dried in  
vacuum desiccator over anhydrous CaCl2 (Scheme 2).  
The purity of synthesized metal complexes has been 
checked by TLC run in 80:20 ratio of 





Metal complexes containing desired ligand 
framework were synthesized by template method in 
good yield in 1:1:1 molar ratio of isatin, metal salt and 
benzene-1, 4-dicarbohydrazide. The formation of 
ligand framework in macrocyclic complexes has been 
inferred on the basis of results obtained from 
elemental analyses, molar conductance, mass spectra 
(Table 1) and FTIR analysis. The molar conductance 
values in dimethylformamide (DMF) have indicated 









. The position of the absorption bands in 
electronic spectra and observed values of magnetic 
moment have revealed the overall geometry of 
molecules. Evidence of the absence of water 
molecules and thermal stability of the complexes was 




Molecular Docking study 
AutoDock 4.2 program was used for the prediction 
of binding energy and searching for the best possible 
binding site together using the Lamarckian genetic 
algorithm. AutoDock Tools were used to carry out 
molecular docking calculations of the synthesized 
metal complexes with protein receptors EGFR kinase 
and tyrosine kinase (TRK)
14-16
. The co-crystal 
structure of EGFR-erlotinib complex (PDB ID: 1M17, 
resolution of 2.6 Å) was downloaded from Protein 
Data Bank and the co-crystal structure of tyrosine 
complex (1t46) obtained with a resolution of 1.60 Å. 
The downloaded protein structures were undergone 
 
 
Scheme 2 — Microwave template synthesis of trivalent metal complexes 
 
 
Scheme 1 — Microwave synthesis of benzene-1, 4-dicarbohydrazide 




―Energy Minimization‖ by using SPDBV 4.10- 
version. All water molecules and ligands were 
removed from the protein complex while hydrogen 
atoms and Kollman charges were added. Active site 
with a radius of 10.5 Å was defined in the receptor 
protein molecule. The three dimensional structure of 
synthesized ligand was drawn by Chem Sketch 
software and the structure was cleaned by using Chem 
Sketch tools and a mol file was generated which was 
converted into PDB format using ―Open Babel Gui 
2.3.2‖. The minimized ligand and metal complexes 
were docked into the active site of EGFR kinase and 
tyrosine kinase receptor molecules. The binding free 
energy of the compounds inside the target receptors 




In vitro antioxidant activity
 
The free radical scavenging activity of complexes 
was evaluated by using DPPH (2, 2-diphenyl-1-
picrylhydrazyl 1, 1-diphenyl-2-picrylhydrazyl) method 
as reported in literature. 10
-3 
M of stock solution of 
DPPH in methanol and solutions of all test 
compounds prepared in the concentration range of  
25-500 µg/ml in DMF were prepared and by 
measuring their absorbance at characteristic 
wavelength of DPPH i.e. 517 nm
17-18
. DMF and 
DPPH were used as negative and positive control, 
respectively. The results were compared with the 
standard antioxidant butylated hydroxyanisole (BHA) 
in the same concentration range. 
 
In vitro cytotoxicity  
SCC4 (Squamous Cell Carcinoma) cell line was 
taken for investigating the cytotoxicity of synthesized 
metal complexes. The growth inhibitory effect  
of the synthesized complexes on human SCC4  
cancer cell line was evaluated by applying MTT  
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium- 
bromide) assay, in which MTT can be easily 
transformed by living cells to produce a DMSO 
soluble product formazan that can be simply detected 
using colorimetric analysis
19-20
. 200 μL ml of medium 
containing the complex at five variable concentrations 
(ranging from 10 μM to 100 μM) and 20 μL of MTT 
solution (5 mg/ml) were used for the assay. Three 
different test timescales (24 h, 48 h, and 72 h) were 
established for each treatment. After discarding the 
medium with MTT, 150 μL of DMSO was added to 
each well to dissolve the formazan crystals. The 
untreated cells containing DMSO and media were 
used as control. BIOTEK ELISA PLATE READER 
was used to check the absorbance at 570 nm 





Results and Discussion  
 
FTIR analysis 
A pair of bands at 3300 cm
-1
 and 3350 cm
-1 
corresponding to ν(NH2) were present in the IR 
spectrum of benzene-1,4-dicarbohydrazide, but absent 
in the spectrum of complexes (Fig. 1). However a 
single medium intensity broad band at 3250–3270cm
-1
 
was observed in the spectrum of complexes, which 
may be assigned to N-H stretching vibrations
14
. 
Furthermore no absorption band was observed at 
~1715 cm
-1
 in the spectrum of complexes  
which indicates the absence of C=O group of  
1H-indole-2,3-dione. It reveals the condensation 
reaction of C=O group of 1H-indole-2, 3-dione and 





. This fact is further supported by 
the appearance of a new strong absorption band at 
1605 cm
-1
 and 1615 cm
-1
 in the spectrum of 
complexes, respectively which may be assigned to 
ν(C═N) stretching vibrations
23-25
. A medium intensity 
Table 1 ― Molecular formula, Elemental analysis, M.P., Color, Molar mass of the metal complexes 
S. N. Mol. Formula Melting point 
(ºC) 
Color Molar mass 
gm/mol 
Calculated 
Elemental analysis calculated(found)% 
C H N M 





























































band at 1650–1657 cm
-1
 in the spectra of metal 
complexes supports the involvement of C=O group in 
coordination with central metal atom. All these results 
strongly give evidence of the formation of N2O2 donor 
macrocyclic frame in the complexes. The peak 
corresponding to N-H stretching has appeared at 
expected position which infers that NH group is not 
contributing in coordination. The bands observed at 
3057–3092 cm
-1
 and 1455–1565 cm
-1
 are assigned to 
C–H and C=C stretching vibrations of aromatic rings 
respectively
26-29
. In the acetate complexes a strong  
band at 1620–1632cm
-1
 and 1320–1375 cm
-1
 was also 
obtained. The difference in frequencies of these two 
bands in IR spectrum suggests that these acetate groups 
are bonded to metal ion in monodentate fashion. 
Moreover the appearance of medium intensity band at 
530–524 cm
-1
 and 425–436 cm
-1
 evident the presence 
of M-O and M-N bonds and further supports the 
coordination through oxygen and nitrogen atom of the 
ligand framework with metal ion
29
. All the significant 
peaks required for characterization of metal complexes 
are summarized in Table 2. 
 
Electronic spectra and magnetic moment analysis 
UV-visible spectra of metal complexes were 
recorded in DMSO at room temperature (Table 3). 
 
Chromium complexes 
Chromium (III) complexes showed magnetic 
moments in the range of 3.72–3.85 B.M which 
indicates the presence of three unpaired electrons
30
. 
The electronic spectrum of the chromium  
complexes recorded in DMSO displays three bands  
at 14,860–15,000 cm
-1

















T1g(P) transitions, respectively. The peak 
appeared at 14860–15,000 cm
-1
 corresponds to the d-d 
transition while the other two peaks raised due to  
n–π* and π–π* transitions of ligand framework 
around the metal. The position of peaks is in good 
agreement with the earlier reported results for the 
octahedral geometry around the Cr(III) ion reported 
by S. Chandra et al. 
31
. The ligand field parameters 
like ligand field splitting energy (10 Dq), Racah  
inter-electronic repulsion parameter (B′), covalency 
factor (β) and ν2/ν1 were calculated for the complexes 
and are listed in Table 4. The Cr(III) complexes 
having a low value of B′ i.e. 812-817, in comparison 
to that of free ion (918 cm
−1
) suggests a significant 
degree of covalence. The values of ν2/ν1 are lying 
between 1.47–1.48 which suggests the octahedral 





Fig. 1 ― FTIR spectrum of [Cr(C16H11N4O2)(NO3)2]NO3 in the 
range of 4000-400 cm-1. 
Table 2 ― IR spectral data for synthesized metal complexes 
S.N. Compound Significant IR peaks (cm-1) 
(ν-NH) (ν–C=O) (ν-C=N) (ν-M-O) (ν-M-N) 
I [Cr(C16H11N4O2)Cl2]Cl 3260 1632 1610 530 425 
II [Cr(C16H11N4O2)(NO3)2]NO3 3257 1657 1615 534 453 
III [Cr(C16H11N4O2)(OAc)2]OAc 3253 1646 1607 521 432 
IV [Fe(C16H11N4O2)(NO3)2] NO3 3250 1639 1595 521 450 
V [Fe(C16H11N4O2)(OAc)2]OAc 3257 1657 1615 524 436 
 
Table 3 ― Electronic spectra, Magnetic moment and Molar conductance data of synthesized metal complexes 

























4T2g 5.91–5.98 69.0-76.0 Octahedral 
 





Fe(III) complexes showed magnetic moments in 
the range 5.91–5.98 BM which is close to the 
predicted value corresponding to five unpaired 
electrons. For iron complexes, Rana et al. have 
reported absorption peak at 17500cm
-1














. Our Fe(III) complexes have  





, corresponding to above said 
transitions, respectively and were consistent with the 
octahedral geometry around Iron (III) ion 
21
. These 
peaks correspond to d-d transition and ligand based 
transition, respectively. 
 
Mass spectral analysis 
The ESI mass spectra of metal complexes were 
recorded and analyzed. The molecular ion (Mþ) peaks 
obtained for metal complexes are as following:  
[Cr (C16H11N4O2) (Cl)2] Cl m/z (447.67),  
[Cr (C16H11N4O2) (NO3)2] NO3 m/z (527.00), 
[Cr(C16H11N4O2)(OAc)2] OAc, m/z (518.10), 
[Fe(C16H11N4O2)(NO3)2] NO3 m/z (531.37) (Fig. 2), 
[Fe(C16H11N4O2)(OAc)2] m/z (522.10). This data is in 
full agreement with the calculated molecular weight 
for these complexes. 
 
Thermal studies 
Evidence of the absence of water molecules and 
thermal stability of the complexes was studied by 
analyzing their TGA data. The thermal degradation of 
metal complexes started at ~240
 
ºC which confirms 
the absence of coordinated or lattice water in the 
complexes (Fig. 3). All TG curves are showing 
stepwise degradation of molecules in the temperature 
range 520–710
 
ºC which may be attributed to the 
removal of anions and organic moiety from the 
complexes. The weight% of the left over matches 
with the weight% of the corresponding air stable 
metal oxides which further supports the composition 
of the complexes
34
.The results related to TGA 




Molecular Docking  
The best binding mode of docked compounds with 
ATP binding site of EGFR kinase (1M17) (Fig. 4) and 
TRK (1T46) was analyzed to find out different types 
of molecular interactions like H-bonding, electrostatic 
and hydrophobic. The complex was extended into the 
active site of EGFR kinase created by amino acid 
residues LEU764, LEU694, GLN767, LEU768, 
ALA719, THR766, PRO770, MET769, GLY772, 
PHE771, THR830, ASP831 and LEU820
30
. The metal 
complexes have shown affinity to the amino acid 
residues of EGFR through H-bonding. These 
interactions reveal significant binding of the 
synthesized Fe(II) complex with the protein receptor 
Table 4 ― Calculated ligand field parameters of metal complexes 
S.N. Complex LFSE10Dq (cm-1)  B′ (cm-1) β ν2/ν1 
1.  [Cr(C16H11N4O2)(OAc)2] (OAc) 14860 812 0.88 1.48 
2.  [Cr(C16H11N4O2) (NO3)2] (NO3) 14950 817 0.89 1.47 








Fig. 3 ― Thermogravimetric (TG) curve of [Cr(C16H11N4O2)- 
(NO3)2]NO3. 
 




molecule contributing to a favourable free binding 
energy The active site of TRK (1T46) is formed by 
TYR846, VAL845, CYS844, THR847, ARG791, 
PHE848, TYR570, ASN566, CYS788, ASN787, 
ILE571 amino acid residues Best binding affinity (ΔG) 
was shown by complex II with these receptor 
molecules with a binding energy of -8.82 and  
-6.64 kcal/mol, respectively. The results obtainedby 
molecular docking of synthesized compounds with 
both the receptor molecules are summarized in Table 6  
Antioxidant activity 
It was observed that antioxidant potential of 
synthesized complexes increased with increasing 
concentration of the metal complexes and standard. 
Complex (III) and (V) have shown significant radical 
scavenging activity with a maximum value 76.8% and 
78.7%, respectively at 500 μg/ml concentration. 
Complex (I) was found least effective antioxidant 
than other complexes. Other complexes have shown 
average antioxidant potential. The results of DPPH 
assay in the form of percentage DPPH scavenging 
activity are summarized in the Table 7. 
 
In vitro anticancer activity  
Results of cytotoxicity of complexes were expressed 
in terms of IC50 values and compared with that of 
standard drug Cisplatin. All the complexes have shown 
significant IC50 value (Table 8, Fig. 5) at 72 h. It was 
found that the average cell viability ratio decreased 
with increasing concentration of the tested compounds. 
Complexes exhibited clearly reduced cell viability in a 
dose-dependent manner showing cytotoxicity IC50 
values against SCC4 cancer cell line. Cr(III) complexes 
were exhibiting better cytotoxicity than the Fe(III) 
complexes. Among all the tested compounds complex 
(II) was found most effective inhibitor for SCC4 cancer 
Table 5 ― Thermo gravimetric analysis (TGA) of metal complexes 



















Remaining mass 10.01(10.11) 











Remaining mass 10.81(10.86) 
 
Table 6 ― Summarized, Molecular docking results of complexes against the receptor molecules 
Compound Receptor protein Amino acid residue Type of interaction Bond length Binding affinity  
ΔG (Kcal/mol) 













Fig. 4 ― Molecular docking of complex II with molecular target 
1M17. 
 




cell line with IC50 value being 39.5 µM at 72 h time 
scale. These results are in full agreement with the 
results of molecular docking study against EGFR and 
TRK biomolecules. The IC50 value shown by this 
complex was found to be better than the earlier 
reported isatin based macrocyclic complexes
16
 against 
SCC4 cancer cell line. 
 
Conclusions  
The metal complexes were synthesized using 
ecofriendly microwave assisted method successfully. 
The metal complexes of tetradentate ligand 
framework are stable in air, colored and biologically 
active. The structure of the ligand and the complexes 
was established by using UV-visible, IR, Mass and 
TGA techniques. The ligand acted as N2O2 donor 
system to form mono-nuclear complexes having 
octahedral geometry. Molecular docking analysis 
revealed that complex II has best binding affinity with 
EGFR and TRK receptor molecules. In vitro 
antioxidant activity of complex V was the best among 
all. Complex II showed potent in vitro cytotoxicity 
(IC50 value 39.5 μM) against SCC4 cancer cell line 
indicating that these complexes may be very 
promising candidates as antitumor agents. 
 
Acknowledgement 
The authors are gratefully thankful to CDRI, 
Lucknow for providing the sophisticated analytical 
instrumental facility and highly acknowledge the 
management of JSS Academy of Technical 




1 Sclafani J A, Maranto M T, Sisk T M & Van Arman S A,  
J Org Chem, 61(9) (1996) 3221. 
2 Lakshmi B, Shivananda K N, Prakash G A, Rama K R K & 
Mahendra K N, Bull. Korean Chem. Soc, 32(5) (2011) 1613. 
3 Chandra S, Jain D & Sharma A K, Spectrochim Acta A,  
71(5) (2009) 1712. 
4 Kajal A, Bala S, Kamboj S, Sharma N & Saini V,  
J Catal, 2013 (2013). 
5 Kumar K, Kamboj M, Jain K & Singh D P, Spectrochim  
Acta A, 128 (2014) 243. 
6 Shvekhgeimer M G, Chem Heterocycl Compd,  
32(3) (2014) 249. 
7 Bergman J, Lindström J O & Tilstam U L F, Tetrahedron, 
41(14) (1985) 2879. 
8 Black D S C, Bowyer M C, Catalano M M, Ivory A J,  
Keller P A, Kumar N & Nugent S J, Tetrahedron,  
50(35) (1994) 10497. 
Table 7 ― DPPH scavenging activity of metal complexes at different concentrations 
S. N. Compounds % antioxidant activity at different concentration (μg/ml) 
25 50 100 250 500 
Standard BHA 26.7 32.3 47.2 74.6 88.3 
I [Cr(C16 H11N4O2)Cl2]Cl 23.5 30.6 37.8 42.5 48.6 
II [Cr(C16 H11N4O2)(NO3)2]NO3 32.5 39.8 45.7 53.4 64.3 
III [Cr(C16H11N4O2)(OAc)2]OAc 34.6 51.7 67.9 72.5 76.8 
IV [Fe(C16 H11N4O2)(NO3)2]NO3 24.6 32.4 39.8 44.6 51.7 
V [Fe(C16H11N4O2)(OAc)2]OAc 39.3 46.8 54.6 62.5 78.7 
 
Table 8 ― Cytotoxicity of test compounds against SCC4 cell line at different time scale 
Sl. no. Compounds IC50 (μM) 
24hrs 48hrs 72hrs 
I [Cr(C16 H11N4O2)Cl2]Cl 62.1 55.7 42.3 
II [Cr(C16 H11N4O2)(NO3)2]NO3 54.1 47.0 39.5 
III [Cr(C16H11N4O2)(OAc)2]OAc 68.9 57.1 44.5 
IV [Fe(C16 H11N4O2)(NO3)2]NO3 86.7 80.4 77.4 
V [Fe(C16H11N4O2)(OAc)2]OAc >100 >100 90.7 




Fig. 5 ― Cytotoxicity of synthesized compounds/standard at 
different time scale. 




9 Subudhi B, Panda P K, Bhatta D & Jena A, Iranian J Pharm 
Sci, 5(2) (2009) 83. 
10 Vine K L, Locke J M, Ranson M, Pyne S G & Bremner J B, 
J Med Chem, 50(21) (2007) 5109. 
11 Cox G, Vyberg M, Melgaard B, Askaa J, Oster A &  
O'Byrne K J, Int J Cancer, 92(4) (2001) 480. 
12 Smith I (Ed.) Chromatography, Elsevier (2013). 
13 Geary W J, Coord Chem Rev, 7(1) (1971) 81. 
14 Rodrigues M A, Gamba C O, Faria J A Q A, Ferreira Ê,  
Goes A M, Gomes D A & Cassali G D, Pathol Res Practice, 
212(4) (2016) 340. 
15 Jain P, Singh V, Ali S, Tripathi V & Saraswat U, J Saudi 
Chem Soc, 22(5) (2018) 546. 
16 Ali S, Singh V, Jain P & Tripathi V, J Saudi Chem Soc,  
23(1) (2019) 52. 
17 Brand-Williams W, Cuvelier M E & Berset C L W T,  
LWT-Food Sci Technol, 28(1) (1995) 25. 
18 Alam M N, Bristi N J & Rafiquzzaman M, Saudi Pharma J, 
21(2) (2013) 143. 
19 Muralisankar M, Haribabu J, Bhuvanesh N S, Karvembu R 
& Sreekanth A, Inorga Chim Acta, 449 (2016) 82. 
20 Zhao J A, Zhao D, Zhao Y, Shu H & Hu J, Polyhedron,  
119 (2016) 7. 
21 Prasad R N & Mathur M, J Serb Chem Soc,  
67(12) (2002) 825. 
22 Khan T A, Rather M A, Jahan N, Varkey S P & Shakir M, 
Transition Met Chem, 23(3) (1998) 283; Khan T A & 
Shagufta M, Transition Met Chem, 24(6) (1999) 669.  
23 Srinivasan S, Athappan P & Rajagopal G, Transition Met 
Chem, 26(4-5) (2001) 588. 
24 Zeng Q, Sun J, Gou S, Zhou K, Fang J & Chen H, Transition 
Met Chem, 23(4) (1998) 371.  
25 Lodeiro C, Bastida R, Bértolo E, Macías A & Rodríguez 
A, Transition Met Chem, 28(4) (2003) 388.  
26 Kantekin H, Ocak Ü, Gök Y & Acar I, J Inclusion Phenom 
Macrocyclic Chem, 48(3-4) (2004) 95. 
27 Shakir M, Islam K S, Mohamed A K, Shagufta M & Hasan S 
S, Transition Met Chem, 24(5) (1999) 577. 
28 Costamagna J, Ferraudi G, Villagran M & Wolcan E, J Chem 
Soc Dalton Transac, (15) (2000) 2631. 
29 Shakir M, Varkey S P & Hameed P S, Polyhedron,  
12(23) (1993) 2775. 
30 Figgis B N & Lewis J, Prog Inorg Chem, 6 (1964) 37. 
31 Chandra S & Gupta K, Transition Met Chem, 27(2) (2002) 
196-199; Chandra S & Gupta L K, Spectrochim Acta A,  
61(9) (2005) 2139. 
32  Sathyanarayana D N, Electronic absorption spectroscopy 
and related techniques. Universities Press, (2001). 
33 Saraswat R & Rana V B, J Indian Chem Soc, 75(9) (1998) 493. 
34 El-Boraey H A & El-Gammal O A, Spectrochim Acta A,  
138 (2015) 553. 
 
